Guilherme Henrique Tamarindo

Dr. Guilherme Henrique Tamarindo

Laboratório de Investigação Molecular no Câncer (LIMC), Faculdade de Medicina de São José do Rio Preto (FAMERP), Avenida Brigadeiro Faria Lima, 5416, São José do Rio Preto 15090-000, Brazil
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2017 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
BSBruno D. A. Sanches
Bruno D. A. Sanches
JMJuliana S. Maldarine
Juliana S. Maldarine
BZBruno C. Zani
Bruno C. Zani
GTGuilherme Henrique Tamarindo
Guilherme Henrique Tamarindo
MBManoel F. Biancardi
Manoel F. Biancardi
STSebastiao Roberto Taboga
Sebastiao Roberto Taboga
Telocytes are CD34‐positive interstitial cells, known to exert several functions, one of which is a role in tissue organisation, previously demonstrated by telocytes in the myocardium. The existence of telocytes in the prostate has recently been reported, however, there is a lack of information regarding the function of these cells in prostate tissue, and information regarding the possible role of these cells in prostatic development. This study used immunofluorescence techniques in prostate tissue and prostatic telocytes in culture to determine the relationship between telocytes and prostate morphogenesis. Furthermore, immunofluorescent labelling of telocytes was performed on prostate tissue at different stages of early postnatal development. Initially, CD34‐positive cells are found at the periphery of the developing alveoli, later in the same region, c‐kit‐positive cells and cells positive for both factors are verified and CD34‐positive cells were predominantly observed in the interalveolar stroma and the region surrounding the periductal smooth muscle. Fluorescence assays also demonstrated that telocytes secrete TGF‐β1 and are ER‐Beta (ERβ) positive. The results suggest that telocytes play a changing role during development, initially supporting the differentiation of periductal and perialveolar smooth muscle, and later, producing dense networks that separate alveoli groups and form a barrier between the interalveolar region and periurethral smooth muscle. We conclude that telocytes play a relevant role in prostate tissue organisation during postnatal development.

15 April 2021 in Cell Biology International
Verified
Journal Article
Closed access
PDF file
BSBruno Domingos Azevedo Sanches
Bruno Domingos Azevedo Sanches
GTGuilherme Henrique Tamarindo
Guilherme Henrique Tamarindo
JMJuliana Dos Santos Maldarine
Juliana Dos Santos Maldarine
ASAlana Della Torre Da Silva
Alana Della Torre Da Silva
VSVitória Alário Dos Santos
Vitória Alário Dos Santos
Hernandes CarvalhoHernandes Carvalho
Hernandes Carvalho

9 January 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
GTGuilherme Henrique Tamarindo
Guilherme Henrique Tamarindo
DRDaniele L. Ribeiro
Daniele L. Ribeiro
MGMarina G. Gobbo
Marina G. Gobbo
LGLuiz H. A. Guerra
Luiz H. A. Guerra
PRPaula Rahal
Paula Rahal
RGRejane Maira Góes
Rejane Maira Góes
Prostate cancer development has been associated with changes in mitochondrial activity and reactive oxygen species (ROS) production. Melatonin (MLT) and docosahexaenoic acid (DHA) have properties to modulate both, but their protective role, mainly at early stages of prostate cancer, remains unclear. In this study, the effects of MLT and DHA, combined or not, on PNT1A cells with regard to mitochondria bioenergetics, ROS production, and proliferation-related pathways were examined. Based on dose response and lipid accumulation assays, DHA at 100 μM and MLT at 1 μM for 48 h were chosen. DHA doubled and MLT reduced (40%) superoxide anion production, but coincubation (DM) did not normalize to control. Hydrogen peroxide production decreased after MLT incubation only (p<0.01). These alterations affected the area and perimeter of mitochondria, since DHA increased whereas MLT decreased, but such hormone has no effect on coincubation. DHA isolated did not change the oxidative phosphorylation rate (OXPHOS), but decreased (p<0.001) the mitochondrial bioenergetic reserve capacity (MBRC) which is closely related to cell responsiveness to stress conditions. MLT, regardless of DHA, ameliorated OXPHOS and recovered MBRC after coincubation. All incubations decreased AKT phosphorylation; however, only MLT alone inhibited p-mTOR. MLT increased p-ERK1/2 and, when combined to DHA, increased GSTP1 expression (p<0.01). DHA did not change the testosterone levels in the medium, whereas MLT alone or coincubated decreased by about 20%; however, any incubation affected AR expression. Moreover, incubation with luzindole revealed that MLT effects were MTR1/2-independent. In conclusion, DHA increased ROS production and impaired mitochondrial function which was probably related to AKT inactivation; MLT improved OXPHOS and decreased ROS which was related to AKT/mTOR dephosphorylation, and when coincubated, the antiproliferative action was related to mitochondrial bioenergetic modulation associated to AKT and ERK1/2 regulation. Together, these findings point to the potential application of DHA and MLT towards the prevention of proliferative prostate diseases.

30 August 2023 in Animals
Verified
Journal Article
Open access
PDF file
GTGuilherme Henrique Tamarindo
Guilherme Henrique Tamarindo
ANAdriana Alonso Novais
Adriana Alonso Novais
Luiz Gustavo ChuffaLuiz Gustavo Chuffa
Luiz Gustavo Chuffa
Debora Aparecida Pires Campos ZuccariDebora Aparecida Pires Campos Zuccari
Debora Aparecida Pires Campos Zuccari
Canine mammary tumors (CMTs) are among the most common diseases in female dogs and share similarities with human breast cancer, which makes these animals a model for comparative oncology studies. In these tumors, metabolic reprogramming is known as a hallmark of carcinogenesis whereby cells undergo adjustments to meet the high bioenergetic and biosynthetic demands of rapidly proliferating cells. However, such alterations are also vulnerabilities that may serve as a therapeutic strategy, which has mostly been tested in human clinical trials but is poorly explored in CMTs. In this dedicated review, we compiled the metabolic changes described for CMTs, emphasizing the metabolism of carbohydrates, amino acids, lipids, and mitochondrial functions. We observed key factors associated with the presence and aggressiveness of CMTs, such as an increase in glucose uptake followed by enhanced anaerobic glycolysis via the upregulation of glycolytic enzymes, changes in glutamine catabolism due to the overexpression of glutaminases, increased fatty acid oxidation, and distinct effects depending on lipid saturation, in addition to mitochondrial DNA, which is a hotspot for mutations. Therefore, more attention should be paid to this topic given that targeting metabolic fragilities could improve the outcome of CMTs.

29 September 2020 in Cell Biology International
Verified
Journal Article
Closed access
PDF file
GTGuilherme Henrique Tamarindo
Guilherme Henrique Tamarindo
MGMarina Guimarães Gobbo
Marina Guimarães Gobbo
STSebastiao Roberto Taboga
Sebastiao Roberto Taboga
EAEduardo Alves Almeida
Eduardo Alves Almeida
RGRejane Maira Góes
Rejane Maira Góes

7 August 2024 in Cancer & Metabolism
Verified
Journal Article
Open access
PDF file
GTGuilherme Henrique Tamarindo
Guilherme Henrique Tamarindo
CRCaroline Fidalgo Ribeiro
Caroline Fidalgo Ribeiro
ASAlana Della Torre da Silva
Alana Della Torre da Silva
Alex CastroAlex Castro
Alex Castro
ICIcaro Caruso
Icaro Caruso
RGRejane Maira Góes
Rejane Maira Góes
Prostate cancer (PCa) shows a rewired metabolism featuring increased fatty acid uptake and synthesis via de novo lipogenesis, both sharply related to mitochondrial physiology. The docosahexaenoic acid (DHA) is an omega-3 polyunsaturated fatty acid (PUFA) that exerts its antitumoral properties via different mechanisms, but its specific action on mitochondria in PCa is not clear. Therefore, we investigated whether the DHA modulates mitochondrial function in PCa cell lines. Here, we evaluated mitochondrial function of non-malignant PNT1A and the castration-resistant (CRPC) prostate 22Rv1 and PC3 cell lines in response to DHA incubation. For this purpose, we used Seahorse extracellular flux assay to assess mitochondria function, [14C]-glucose to evaluate its oxidation as well as its contribution to fatty acid synthesis, 1H-NMR for metabolite profile determination, MitoSOX for superoxide anion production, JC-1 for mitochondrial membrane polarization, mass spectrometry for determination of phosphatidylglycerol levels and composition, staining with MitoTracker dye to assess mitochondrial morphology under super-resolution in addition to Transmission Electron Microscopy, In-Cell ELISA for COX-I and SDH-A protein expression and flow cytometry (Annexin V and 7-AAD) for cell death estimation. In all cell lines DHA decreased basal respiratory activity, ATP production, and the spare capacity in mitochondria. Also, the omega-3 induced mitochondrial hyperpolarization, ROS overproduction and changes in membrane phosphatidylglycerol composition. In PNT1A, DHA led to mitochondrial fragmentation and it increased glycolysis while in cancer cells it stimulated glucose oxidation, but decreased de novo lipogenesis specifically in 22Rv1, indicating a metabolic shift. In all cell lines, DHA modulated several metabolites related to energy metabolism and it was incorporated in phosphatidylglycerol, a precursor of cardiolipin, increasing the unsaturation index in the mitochondrial membrane. Accordingly, DHA triggered cell death mainly in PNT1A and 22Rv1. In conclusion, mitochondrial metabolism is significantly affected by the PUFA supplementation to the point that cells are not able to proliferate or survive under DHA-enriched condition. Moreover, combination of DHA supplementation with inhibition of metabolism-related pathways, such as de novo lipogenesis, may be synergistic in castration-resistant prostate cancer.